Exit Readiness Program for PE-Backed Cardiology Portfolio
15 months | Exit readiness advisory + ongoing commercial coaching
The Challenge
A PE-backed cardiology device company was 15 months away from planned exit and needed to strengthen commercial fundamentals and build a compelling growth narrative. Initial valuation expectations exceeded multiples the market was paying for comparable companies. Management needed a roadmap to close the valuation gap.
Our Approach
We developed a 15-month exit readiness program focused on de-risking the commercial story and capturing incremental value. We conducted a gap analysis against buyer evaluation criteria, identified margin expansion opportunities, strengthened key account relationships, and built documented proof points for the growth narrative. We also coached management on investor pitch positioning and due diligence readiness.
Results
- Achieved 18% revenue growth vs. 8% historical CAGR
- Expanded EBITDA margin from 22% to 31% through pricing and mix optimization
- Secured 5 strategic partnership agreements de-risking geographic expansion
- Closed exit at 8.2x EBITDA (vs. 6.5x initial market expectation)
- Achieved £280M enterprise value